- Home
- ATRC vs BAK Comparison
ATRC vs BAK Comparison
Compare ATRC & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- BAK
- Stock Information
- Founded
- ATRC 2000
- BAK 1972
- Country
- ATRC United States
- BAK Brazil
- Employees
- ATRC N/A
- BAK N/A
- Industry
- ATRC Medical/Dental Instruments
- BAK Major Chemicals
- Sector
- ATRC Health Care
- BAK Industrials
- Exchange
- ATRC Nasdaq
- BAK Nasdaq
- Market Cap
- ATRC 1.6B
- BAK 1.4B
- IPO Year
- ATRC 2005
- BAK N/A
- Fundamental
- Price
- ATRC $29.30
- BAK $3.04
- Analyst Decision
- ATRC Strong Buy
- BAK Strong Buy
- Analyst Count
- ATRC 10
- BAK 3
- Target Price
- ATRC $49.50
- BAK $9.75
- AVG Volume (30 Days)
- ATRC 380.2K
- BAK 1.1M
- Earning Date
- ATRC 07-29-2025
- BAK 08-06-2025
- Dividend Yield
- ATRC N/A
- BAK N/A
- EPS Growth
- ATRC N/A
- BAK N/A
- EPS
- ATRC N/A
- BAK N/A
- Revenue
- ATRC $480,076,000.00
- BAK $13,770,122,923.00
- Revenue This Year
- ATRC $14.63
- BAK $18.11
- Revenue Next Year
- ATRC $12.62
- BAK $7.32
- P/E Ratio
- ATRC N/A
- BAK N/A
- Revenue Growth
- ATRC 15.79
- BAK 14.35
- 52 Week Low
- ATRC $20.20
- BAK $2.85
- 52 Week High
- ATRC $43.11
- BAK $7.71
- Technical
- Relative Strength Index (RSI)
- ATRC 37.20
- BAK 40.84
- Support Level
- ATRC $29.60
- BAK $3.27
- Resistance Level
- ATRC $30.69
- BAK $3.80
- Average True Range (ATR)
- ATRC 0.96
- BAK 0.10
- MACD
- ATRC -0.19
- BAK -0.00
- Stochastic Oscillator
- ATRC 9.58
- BAK 15.00
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.